A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance

Metabolism: Clinical and Experimental

Volumn 62, Issue 1, 2013, Pages 34-38

  O'Sullivan, Eoin P ^a   Ashley, David T ^b   Davenport, Colin ^a   Penugonda, Lakshmi ^a   Kelleher, Grainne ^a   Devlin, Niamh ^b   Crowley, Rachel ^a   O'Shea, Paula ^a   Agha, Amar ^a   Thompson, Chris J ^a   O'Gorman, Donal J ^b   Smith, Diarmuid ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Abnormal glucose tolerance; Diabetes; HOMA IR

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; OSTEOPROTEGERIN;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; OSTEOPROTEGERIN;

EID: 84870935191     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.06.005     Document Type: Article

References (21)

1. DeFronzo, R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270-87.
2. A. Pfutzner, and T. Forst High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus Diabetes Technol Ther 8 2006 28 36
3. Y. Matsuzawa Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease Atheroscler Suppl 6 2005 7 14
4. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, and R. Luthy Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
5. E. Tsuda, M. Goto, S. Mochizuki, K. Yano, F. Kobayashi, and T. Morinaga Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis Biochem Biophys Res Commun 234 1997 137 142
6. S. Jono, Y. Ikari, A. Shioi, K. Mori, T. Miki, and K. Hara Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease Circulation 106 2002 1192 1194
7. S.T. Knudsen, C.H. Foss, P.L. Poulsen, N.H. Andersen, C.E. Mogensen, and L.M. Rasmussen Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications Eur J Endocrinol 149 2003 39 42
8. E.P. O'Sullivan, D.T. Ashley, C. Davenport, N. Devlin, R. Crowley, and A. Agha Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes Diabetes Metab Res Rev 26 2010 496 502
9. S.M. Kim, J. Lee, O.H. Ryu, K.W. Lee, H.Y. Kim, and J.A. Seo Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity Clin Endocrinol (Oxf) 63 2005 594 598
10. B. Akinci, A. Celtik, F. Yuksel, S. Genc, S. Yener, and M. Secil Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome Diabetes Res Clin Pract 91 2011 26 31
11. Federation, W.H.O.I.D. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006
12. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
13. M.H. Gannage-Yared, C. Yaghi, B. Habre, S. Khalife, R. Noun, and M. Germanos-Haddad Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study Eur J Endocrinol 158 2008 353 359
14. S. Yaturu, J. Rains, and S.K. Jain Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes Cytokine 44 2008 168 171
15. C.E. Pepene, I.R. Ilie, I. Marian, and I. Duncea Circulating osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction Eur J Endocrinol 164 2011 61 68
16. D.T. Ashley, E.P. O'Sullivan, C. Davenport, N. Devlin, R.K. Crowley, and N. McCaffrey Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects Metabolism 60 2011 994 1000
17. B. Ugur-Altun, A. Altun, M. Gerenli, and A. Tugrul The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity Diabetes Res Clin Pract 68 2005 217 222
18. B. Ugur-Altun, and A. Altun Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women Arch Med Res 38 2007 891 896
19. D. Hofso, T. Ueland, H. Hager, T. Jenssen, J. Bollerslev, and K. Godang Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose Eur J Endocrinol 161 2009 451 458
20. R. Sodi, M.J. Hazell, B.H. Durham, C. Rees, L.R. Ranganath, and W.D. Fraser The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism Clin Biochem 42 2009 1375 1380
21. V. Carnevale, E. Romagnoli, and E. D'Erasmo Skeletal involvement in patients with diabetes mellitus Diabetes Metab Res Rev 20 2004 196 204